Valérie Vouret-Craviari (Valerie Vouret-Craviari)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Immune Response

Top Venues

Nature communications

Purinergic signalling

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Janho Dit Hreich, Thierry Juhel, Sylvie Leroy, Alina Ghinet, Frederic Brau, Veronique Hofman, Paul Hofman, Valérie Vouret-Craviari
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis. eLife 12 (2024)
Serena Janho Dit Hreich, Thierry Juhel, Sylvie Leroy, Alina Ghinet, Frederic Brau, Veronique Hofman, Paul Hofman, Valérie Vouret-Craviari
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis. eLife 12 (2024)
Serena Janho Dit Hreich, Thierry Juhel, Sylvie Leroy, Alina Ghinet, Frederic Brau, Veronique Hofman, Paul Hofman, Valérie Vouret-Craviari
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis. eLife 12 (2024)
Serena Janho Dit Hreich, Thierry Juhel, Sylvie Leroy, Alina Ghinet, Frederic Brau, Veronique Hofman, Paul Hofman, Valérie Vouret-Craviari
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis. eLife 12 (2024)
Serena Janho Dit Hreich, Olivier Humbert, Tanguy Pacé-Loscos, Renaud Schiappa, Thierry Juhel, Véronique Hofman, Victoria Ferrari, Jonathan Benzaquen, Paul Hofman, Valérie Vouret-Craviari
Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation. Cancers 16 (12) (2024)
Serena Janho Dit Hreich, Olivier Humbert, Tanguy Pacé-Loscos, Renaud Schiappa, Thierry Juhel, Véronique Hofman, Victoria Ferrari, Jonathan Benzaquen, Paul Hofman, Valérie Vouret-Craviari
Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation. Cancers 16 (12) (2024)
Serena Janho Dit Hreich, Paul Hofman, Valérie Vouret-Craviari
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity. International journal of molecular sciences 24 (11) (2023)
Serena Janho Dit Hreich, Jonathan Benzaquen, Paul Hofman, Valérie Vouret-Craviari
The Purinergic Landscape of Non-Small Cell Lung Cancer. Cancers 14 (8) (2022)
Laetitia Douguet, Serena Janho Dit Hreich, Jonathan Benzaquen, Laetitia Seguin, Thierry Juhel, Xavier Dezitter, Christophe Duranton, Bernhard Ryffel, Jean Kanellopoulos, Cécile Delarasse, Nicolas Renault, Christophe Furman, Germain Homerin, Chloé Féral, Julien Cherfils-Vicini, Régis Millet, Sahil Adriouch, Alina Ghinet, Paul Hofman, Valérie Vouret-Craviari
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy. Nature communications 12 (1) (2021)
Serena Janho Dit Hreich, Jonathan Benzaquen, Paul Hofman, Valérie Vouret-Craviari
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question. Purinergic signalling (2021)